An FcRn-targeted mucosal vaccine against SARS-CoV-2 infection and transmission
W. Li, T. Wang, A. Mekhemadhom Rajendrakumar…·X. Zhu
This study develops an FcRn-targeted mucosal vaccine that reduces SARS-CoV-2 infection and transmission in mice and hamsters by inducing protective immune responses in the airways.